STOCK TITAN

CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CTI BioPharma Corp. (NASDAQ: CTIC) will present a corporate overview at the Cowen 41st Annual Health Care Conference on March 4, 2021, at 12:10 p.m. EST. This virtual event will be available for live webcast and replay on their website. The company focuses on developing targeted therapies for blood-related cancers, particularly myelofibrosis, and is also exploring treatments for COVID-19. The presentation will provide insights into CTI BioPharma's ongoing projects and strategic direction.

Positive
  • None.
Negative
  • None.

SEATTLE, Feb. 25, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen 41st Annual Health Care Conference at 12:10 p.m. EST. The conference will be held in a virtual meeting format.

Presentation details:

Event: Cowen 41st Annual Health Care Conference
Date: Thursday, Mar. 4, 2021
Time: 12:10 p.m. EST

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.

About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in Seattle, Washington.

CTI BioPharma Investor Contacts:

Maeve Conneighton/Maghan Meyers

+212-600-1902

cti@argotpartners.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-cowen-41st-annual-health-care-conference-on-thursday-mar-4-301235382.html

SOURCE CTI BioPharma Corp.

FAQ

When is CTI BioPharma's presentation at the Cowen 41st Annual Health Care Conference?

CTI BioPharma's presentation is scheduled for March 4, 2021, at 12:10 p.m. EST.

How can I watch CTI BioPharma's presentation live?

The presentation will be webcast live and available for replay on CTI BioPharma's website.

What is the focus of CTI BioPharma's drug development?

CTI BioPharma focuses on developing targeted therapies for blood-related cancers, including myelofibrosis.

Is CTI BioPharma developing any treatments for COVID-19?

Yes, CTI BioPharma has started developing pacritinib for use in hospitalized patients with severe COVID-19.

Where is CTI BioPharma headquartered?

CTI BioPharma is headquartered in Seattle, Washington.

CTIC

NASDAQ:CTIC

CTIC Rankings

CTIC Latest News

CTIC Stock Data

1.20B
123.11M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Seattle